🇺🇸 FDA
Patent

US 9333251

Vaccine for protection against Shigella sonnei disease

granted A61KA61K2039/522A61K39/0283

Quick answer

US patent 9333251 (Vaccine for protection against Shigella sonnei disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/522, A61K39/0283, A61P, A61P31/04